Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction

Activation of the PDGF receptor on human arterial smooth muscle cells (SMC) induces migration and proliferation via separable signal transduction pathways. Sphingosine-1-phosphate (Sph-1-P) can be formed following PDGF receptor activation and therefore may be implicated in PDGF-receptor signal transduction. Here we show that Sph-1-P does not significantly affect PDGF-induced DNA synthesis, proliferation, or activation of mitogenic signal transduction pathways, such as the mitogen-activated protein (MAP) kinase cascade and PI 3-kinase, in human arterial SMC. On the other hand, Sph-1-P strongly mimics PDGF receptor-induced chemotactic signal transduction favoring actin filament disassembly. Although Sph-1-P mimics PDGF, exogenously added Sph-1-P induces more prolonged and quantitatively greater PIP2 hydrolysis compared to PDGF-BB, a markedly stronger calcium mobilization and a subsequent increase in cyclic AMP levels and activation of cAMP-dependent protein kinase. This excessive and prolonged signaling favors actin filament disassembly by Sph-1-P, and results in inhibition of actin nucleation, actin filament assembly and formation of focal adhesion sites. Sph-1-P-induced interference with the dynamics of PDGF-stimulated actin filament disassembly and assembly results in a marked inhibition of cell spreading, of extension of the leading lamellae toward PDGF, and of chemotaxis toward PDGF. The results suggest that spatial and temporal changes in phosphatidylinositol turnover, calcium mobilization and actin filament disassembly may be critical to PDGF-induced chemotaxis and suggest a possible role for endogenous Sph-1-P in the regulation of PDGF receptor chemotactic signal transduction.

[1]  S. Hakomori,et al.  Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. , 1995, Blood.

[2]  D. Clapham,et al.  Calcium signaling , 1995, Cell.

[3]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[4]  S. Hakomori,et al.  Quantification of free sphingosine in cultured cells by acylation with radioactive acetic anhydride. , 1994, Analytical biochemistry.

[5]  F. Fay,et al.  Mediation of chemoattractant-induced changes in [Ca2+]i and cell shape, polarity, and locomotion by InsP3, DAG, and protein kinase C in newt eosinophils , 1994, The Journal of cell biology.

[6]  D. Gill,et al.  Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. , 1994, The Journal of biological chemistry.

[7]  R. Singer,et al.  Beta-actin mRNA localization is regulated by signal transduction mechanisms , 1994, The Journal of cell biology.

[8]  R. Kolesnick,et al.  The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling , 1994, Cell.

[9]  M. Berridge,et al.  Spatial and temporal signalling by calcium. , 1994, Current opinion in cell biology.

[10]  E. Krebs,et al.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. , 1994, The Journal of clinical investigation.

[11]  S. Laulederkind,et al.  Sphingosine-mediated phosphatidylinositol metabolism and calcium mobilization. , 1994, The Journal of biological chemistry.

[12]  S. Spiegel,et al.  Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. , 1994, The Journal of biological chemistry.

[13]  B. Zetter,et al.  Regulation of chemotaxis by the platelet-derived growth factor receptor-β , 1994, Nature.

[14]  L. Claesson-Welsh,et al.  Signal transduction by the PDGF receptors. , 1994, Progress in growth factor research.

[15]  E. Krebs,et al.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Kreisberg,et al.  Regulation of integrin‐mediated adhesion at focal contacts by cyclic AMP , 1993, Journal of cellular physiology.

[17]  S. Spiegel,et al.  Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens , 1993, Nature.

[18]  M. Kester,et al.  Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells. , 1993, The American journal of physiology.

[19]  T. Stossel On the crawling of animal cells. , 1993, Science.

[20]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[21]  A. Kazlauskas,et al.  Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal , 1993, Cell.

[22]  M. White,et al.  IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. , 1993, Endocrinology.

[23]  J. Cooper,et al.  Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1. , 1993, Molecular biology of the cell.

[24]  T. Mitchison Compare and contrast actin filaments and microtubules. , 1992, Molecular biology of the cell.

[25]  U. Hellman,et al.  Identification of two C‐terminal autophosphorylation sites in the PDGF beta‐receptor: involvement in the interaction with phospholipase C‐gamma. , 1992, The EMBO journal.

[26]  Y. Igarashi,et al.  Chemical synthesis of D-erythro-sphingosine-1-phosphate, and its inhibitory effect on cell motility , 1992 .

[27]  C. Turck,et al.  Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways , 1992, Cell.

[28]  S. Schwartz,et al.  Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. , 1992, The Journal of clinical investigation.

[29]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[30]  S. Spiegel,et al.  Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation , 1991, The Journal of cell biology.

[31]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[32]  S. Hakomori Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. , 1990, The Journal of biological chemistry.

[33]  M. Lampugnani,et al.  Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[34]  D. Gill,et al.  Intracellular calcium release mediated by sphingosine derivatives generated in cells. , 1990, Science.

[35]  A. Gown,et al.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.

[36]  R. Ross,et al.  Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF. , 1990, Growth factors.

[37]  London P. Cuatrecasas Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.

[38]  T. Fleming,et al.  Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Hakomori,et al.  Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. , 1989, Biochemistry.

[40]  C. Heldin,et al.  Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor. , 1988, Experimental cell research.

[41]  Arthur C. Guyton,et al.  Handbook of Physiology—The Cardiovascular System , 1985 .

[42]  W. Pledger,et al.  Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells , 1985, The Journal of cell biology.

[43]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[44]  J.,et al.  Platelet-derived Growth factor-induced Alterations Vinculin and Actin Distribution in BALB / c-3 T 3 Cells in , 1984 .

[45]  Gary R. Grotendorst,et al.  Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells , 1982, Journal of cellular physiology.

[46]  Gary R. Grotendorst,et al.  Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[48]  Jonathan A. Cooper,et al.  Phosphorylation Sites at the C-terminus of the Platelet-Derived Growth Factor Receptor Bind Phospholipase Cyl , 2022 .